Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
12/2005
12/01/2005US20050267130 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4
12/01/2005US20050267112 intravenous or oral administration; hypotensive agents; enzyme inhibitors of cGMP-metabolizing phosphodiesterases
12/01/2005US20050267100 For therapy of obesity
12/01/2005DE102004024271A1 Verbindungen enthaltend 3,4-Methylendioxythiophen-Einheiten Compounds containing 3,4-methylenedioxythiophene units
11/2005
11/30/2005EP1599478A1 Dihydropteridinones, method for the production and use thereof in the form of drugs
11/30/2005EP1401839B9 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/24/2005WO2005111047A1 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/24/2005WO2005111045A1 MONO-, OLIGO- AND POLYTHIENO[3,2-b]THIOPHENES
11/24/2005WO2005111039A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
11/24/2005US20050261329 administering morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide for prevention or treatment of viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261272 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
11/24/2005DE4205306B4 Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden Acid amides, drugs with the same and method for the preparation of acid amides
11/24/2005CA2564027A1 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/23/2005EP1598657A1 Method for the determination of absolute configuration of chiral compounds
11/23/2005EP1598358A1 compounds comprising 3,4-methylendioxythiophene units
11/23/2005EP1468112A4 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis
11/22/2005US6967207 Preventive or therapeutic agents for gastric or esophageal regurgitation
11/22/2005CA2184101C Carbapenem derivatives
11/17/2005US20050256102 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine
11/17/2005US20050256096 Having another functional group or pharmacophore covalently attached through a carbamate linkage, e.g., 25-O-Desacetyl-N-(1-carbonyl-4-methyl-piperazine) 3-morpholino rifamycin S; dual-function antibiotic mechanism provides for reduced frequency of resistance.
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/16/2005EP1594872A1 Cannabinoid receptor ligands and uses thereof
11/16/2005EP1347982B1 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005EP1222191B1 Benzodiazepin derivatives, the production and use thereof
11/16/2005CN1696135A Method for purifying Vinorelbine Bitartrate
11/16/2005CN1696132A Compound comprising 3,4-methylendioxythiophene units
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/10/2005WO2005105814A1 Tetracyclic inhibitors of janus kinases
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250763 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/09/2005EP1592426A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1066266B1 Cyclin dependent kinase inhibitors
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005US6962926 monocyte chemoattractant protein-1 (MCP-1); 1-{1,3-dimethyl-6-[2-(pyrrolidin-1-yl)ethoxy]-1H-pyrazolo[3,4-b]pyridine-5-carbonyl}-3-(3-isopropoxyphenyl)urea; inflammatory/autoimmune diseases (multiple sclerosis), and allergic hypersensitivity
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/03/2005WO2005103051A1 Inhibitors of the hiv integrase enzyme
11/03/2005WO2005103003A2 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
11/03/2005US20050245576 Substituted pyrazoles
11/03/2005US20050245565 Diamine derivatives
11/03/2005US20050245561 Anti-tumour polycyclic carboxamides
11/03/2005US20050244938 Manzamine-producing actinomycetes
11/03/2005DE102004018796A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/03/2005CA2564356A1 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/01/2005US6960662 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
10/2005
10/27/2005WO2005100360A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100351A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
10/27/2005WO2005085250A8 C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases
10/27/2005US20050240025 Method for producing imidazolium salts
10/27/2005US20050239788 Substituted with pyrrolopiperazine; schizophrenia, psychosis, depression; inhibition of the 5-HT6 receptor
10/27/2005US20050239784 3-Phenyl analogs of toxoflavine as kinase inhibitors
10/27/2005US20050239780 Tetrahydropyran derivative
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/27/2005DE102004018794A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
10/27/2005CA2563386A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005CA2563010A1 Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-1-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor
10/27/2005CA2562529A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
10/26/2005CN1688582A Fused azole-pyrimidine derivatives
10/26/2005CN1687078A Method for processing production raw materials of vinca alkaloid
10/26/2005CN1687077A Method for preparing verticillium bacteria A and application
10/20/2005US20050234102 Inhibiting the proteolytic activity of cathepsin S, comprising exposing cathepsin S to compounds such as 1-[4-(5-Chloro-1H-indol-3-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol
10/20/2005US20050234092 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234076 Triazolopyrimidines
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/19/2005EP1585481A2 Pyrazolopyrimidine compound and process for preparing the same
10/13/2005WO2005095407A1 M3 muscarinic acetylcholine receptor antagonists
10/13/2005WO2005095400A1 Azaindoles useful as inhibitors of jak and other protein kinases
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005US20050228086 Selective oxidation of sodium sulfide in kraft cooking liquors
10/13/2005US20050228003 Mitotic kinesin inhibitors
10/13/2005US20050227309 Optically-detectable enzyme substrates and their method of use
10/13/2005CA2560454A1 Azaindoles useful as inhibitors of jak and other protein kinases
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/11/2005US6953793 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection
10/11/2005US6953679 Biosynthesis with enzyme or microorganism, catalyzing hydroxylation reaction, useful as modulators of nuclear hormone receptor, anticarcinogenic agents, immunomodulators, steroid mimic
10/06/2005WO2005092901A1 Novel compound and organic electronic device using such compound
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222198 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
10/06/2005US20050222197 Novel pyrazolopyridine derivatives as pharmaceutical agents
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005US20050222179 Adenosine receptor antagonists and methods of making and using the same
10/06/2005US20050222172 Active ingredient in treating neurodegenerative disease, Alzheimer's disease caused by abnormal enzyme activity
10/06/2005US20050222155 Inhibitors of akt activity
10/06/2005US20050222131 Useful as antitumour agents
10/05/2005EP1582522A1 Intermediate for 2-substituted carbapenem derivative and production process
10/05/2005EP1581561A2 Spirotetrathiocarbamates and spirooxothiocarbamates
10/05/2005EP1581539A2 Novel tyrosine kinase inhibitors
10/05/2005EP1404683B1 Polymerisable charge transport compounds
10/05/2005CN1678372A Heterocyclic aromatic compounds useful as growth hormone secretagogues
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 111